• 1
    Barratt A, Irwig L, Glasziou P, Cumming RG, Raffle A, Hicks N, et al. Users’ guides to the medical literature: XVII. How to use guidelines and recommendations about screening. Evidence-Based Medicine Working Group. JAMA 1999;281:202934.
  • 2
    Maissi E, Marteau TM, Hankins M, Moss S, Legood R, Gray A. The psychological impact of human papillomavirus testing in women with borderline or mildly dyskaryotic cervical smear test results: 6-month follow-up. Br J Cancer 2005;92:9904.
  • 3
    Kavanagh AM, Broom DH. Women’s understanding of abnormal cervical smear test results: a qualitative interview study. BMJ (Clinical research ed.) 1997;314:138891.
  • 4
    Korfage IJ, van Ballegooijen M, Huveneers H, Essink-Bot ML. Anxiety and borderline PAP smear results. Eur J Cancer 2010;46:13441.
  • 5
    Wardle J, Pernet A, Stephens D. Psychological consequences of positive results in cervical cancer screening. Psychol Health 1995;10:18594.
  • 6
    Alder E, Foxwell M. Anxiety and cervical screening. J Reprod Infant Psychol 1999;17:199203.
  • 7
    Ronco G, van Ballegooijen M, Becker N, Chil A, Fender M, Giubilato P, et al. Process performance of cervical screening programmes in Europe. Eur J Cancer 2009;45:265970.
  • 8
    Rebolj M, van Ballegooijen M, Berkers LM, Habbema D. Monitoring a national cancer prevention program: successful changes in cervical cancer screening in the Netherlands. Int J Cancer 2007;120:80612.
  • 9
    Dolan P. Modeling valuations for EuroQol health states. Med Care 1997;35:1095108.
  • 10
    Gandek B, Ware JE, Aaronson NK, Apolone G, Bjorner JB, Brazier JE, et al. Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 1998;51:11718.
  • 11
    Ware JE, Kosinski MA, Turner-Bowker DM, Gandek B. How to score version 2 of the SF-12 Health Survey. Boston, MA: QualityMetric Incorporated, 2002.
  • 12
    van der Bij AK, de Weerd S, Cikot RJ, Steegers EA, Braspenning JC. Validation of the dutch short form of the state scale of the Spielberger State-Trait Anxiety Inventory: considerations for usage in screening outcomes. Community Genet 2003;6:847.
  • 13
    Marteau TM, Bekker H. The development of a six-item short-form of the state scale of the Spielberger State-Trait Anxiety Inventory (STAI). Br J Clin Psychol 1992;31:3016.
  • 14
    Millar K, Jelicic M, Bonke B, Ashbury AJ. Assessment of preoperative anxiety: comparison of measures in patients awaiting surgery for breast cancer. Br J Anaesth 1995;74:1803.
  • 15
    Cockburn J, De Luise T, Hurley S, Clover K. Development and validation of the PCQ: a questionnaire to measure the psychological consequences of screening mammography. Soc Sci Med 1992;34:112934.
  • 16
    Ong G, Austoker J, Brett J. Breast screening: adverse psychological consequences one month after placing women on early recall because of a diagnostic uncertainty. A multicentre study. J Med Screen 1997;4:15868.
  • 17
    Rijnsburger AJ, Essink-Bot ML, van As E, Cockburn J, de Koning HJ. Measuring psychological consequences of screening: adaptation of the psychological consequences questionnaire into Dutch. Qual Life Res 2006;15:93340.
  • 18
    Ware JEJ, Snow KK, Kosinski M, Gandek BG. SF-36 health survey: manual and interpretation guide. Boston, MA: The Health Institute New England Medical Center, 1993.
  • 19
    Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 2003;41:58292.
  • 20
    Seehusen DA, Johnson DR, Earwood JS, Sethuraman SN, Cornali J, Gillespie K, et al. Improving women’s experience during speculum examinations at routine gynaecological visits: randomised clinical trial. BMJ (Clinical research ed.) 2006;333:171.
  • 21
    Yanikkerem E, Ozdemir M, Bingol H, Tatar A, Karadeniz G. Women’s attitudes and expectations regarding gynaecological examination. Midwifery 2009;25:5008.
  • 22
    Brett J, Bankhead C, Henderson B, Watson E, Austoker J. The psychological impact of mammographic screening. A systematic review. Psychooncology 2005;14:91738.
  • 23
    Korfage IJ, Essink-Bot ML, Mols F, van de Poll-Franse L, Kruitwagen R, van Ballegooijen M. Health-related quality of life in cervical cancer survivors: a population-based survey. Int J Radiat Oncol Biol Phys 2009;5:15019.
  • 24
    Health Council of the Netherlands. Population screening for cervical cancer. The Hague:Health Council of the Netherlands, 2011 Contract No: publication no. 2011/07.